Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 29, Issue 2, 2019, Pages 201-208

  Esmaeilinezhad, Z ^a   Babajafari, S ^a   Sohrabi, Z ^a   Eskandari, M H ^c   Amooee, S ^b   Barati Boldaji, R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY   (Iran)

Author keywords

Gut microbiota; Insulin resistance; Polycystic ovarian syndrome; Punicaceae; Synbiotic

Indexed keywords

FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PROBIOTIC AGENT; TESTOSTERONE; BIOLOGICAL MARKER; INULIN; SEX HORMONE; SYNBIOTIC AGENT;

ADULT; ANTHROPOMETRY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; COLORIMETRY; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HIP CIRCUMFERENCE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; POMEGRANATE JUICE; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; WAIST CIRCUMFERENCE; WAIST HIP RATIO; YOUNG ADULT; ADOLESCENT; BLOOD; DIET THERAPY; FEMALE; FRUIT AND VEGETABLE JUICE; GROWTH, DEVELOPMENT AND AGING; IRAN; LACTOBACILLUS; LYTHRACEAE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTHROPOMETRY; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; FRUIT AND VEGETABLE JUICES; GONADAL STEROID HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; INULIN; IRAN; LACTOBACILLUS; LUTEINIZING HORMONE; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PROBIOTICS; PUNICACEAE; SYNBIOTICS; TESTOSTERONE; TIME FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 85057750566     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2018.07.002     Document Type: Article

References (35)

1. Tsilchorozidou, T., Overton, C., Conway, G.S., The pathophysiology of polycystic ovary syndrome. Clin Endocrinol 60:1 (2004), 1–17.
2. Cassar, S., Teede, H.J., Harrison, C.L., Joham, A.E., Moran, L.J., Stepto, N.K., Biomarkers and insulin sensitivity in women with polycystic ovary syndrome: characteristics and predictive capacity. Clin Endocrinol 83:1 (2015), 50–58.
3. Park, C.-H., Chun, S., Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome. Obstet Gynecol Sci 59:6 (2016), 498–505.
4. Guo, Y., Qi, Y., Yang, X., Zhao, L., Wen, S., Liu, Y., et al. Association between polycystic ovary syndrome and gut microbiota. PLoS One, 11(4), 2016 e0153196.
5. Zahiri, Z., Sharami, S.H., Milani, F., Mohammadi, F., Kazemnejad, E., Ebrahimi, H., et al. Syndrome in patients with polycystic ovary syndrome in Iran. Int J Fertil Steril, 9(4), 2016, 490.
6. Barber, T., McCarthy, M., Wass, J., Franks, S., Obesity and polycystic ovary syndrome. Clin Endocrinol 65:2 (2006), 137–145.
7. Tremellen, K., Pearce, K., Dysbiosis of gut microbiota (DOGMA) – a novel theory for the development of polycystic ovarian syndrome. Med Hypotheses 79:1 (2012), 104–112.
8. Pasquali, R., Focus on novel developments of PCOS: conclusions from the PCOS Task Force: treatment of PCOS. 2014.
9. Boulangé C.L., Neves, A.L., Chilloux, J., Nicholson, J.K., Dumas, M.-E., Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med, 8(1), 2016, 42.
10. Papadimitriou, K., Zoumpopoulou, G., Foligné B., Alexandraki, V., Kazou, M., Pot, B., et al. Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front Microbiol, 6, 2015.
11. Phoem, A.N., Chanthachum, S., Voravuthikunchai, S.P., Applications of microencapsulated Bifidobacterium longum with Eleutherine Americana in fresh milk tofu and pineapple juice. Nutrients 7:4 (2015), 2469–2484.
12. Kumar, B.V., Vijayendra, S.V.N., Reddy, O.V.S., Trends in dairy and non-dairy probiotic products-a review. J Food Sci Technol 52:10 (2015), 6112–6124.
13. Brunkwall, L., Chen, Y., Hindy, G., Rukh, G., Ericson, U., Barroso, I., et al. Sugar-sweetened beverage consumption and genetic predisposition to obesity in 2 Swedish cohorts. Am J Clin Nutr 104:3 (2016), 809–815.
14. Sichieri, R., Yokoo, E.M., Pereira, R.A., Veiga, G.V., Water and sugar-sweetened beverage consumption and changes in BMI among Brazilian fourth graders after 1-year follow-up. Public Health Nutr 16:1 (2012), 73–77.
15. Bazzano, L.A., Li, T.Y., Joshipura, K.J., Hu, F.B., Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 31:7 (2008), 1311–1317.
16. Viladomiu, M., Hontecillas, R., Lu, P., Bassaganya-Riera, J., Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evid Based Compl Alternative Med, 2013, 2013.
17. Kelley, C.E., Brown, A.J., Diehl, A.M., Setji, T.L., Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol WJG, 20(39), 2014, 14172.
18. Shoaei, T., Heidari-Beni, M., Tehrani, H.G., Effects of probiotic supplementation on pancreatic β-cell function and c-reactive protein in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Int J Prev Med, 6, 2015.
19. Saghaei, M., Random allocation software for parallel group randomized trials. BMC Med Res Meth, 4(1), 2004, 26.
20. Basu, A., Newman, E.D., Bryant, A.L., Lyons, T.J., Betts, N.M., Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study. J Nutr Metabol, 2013, 2013.
21. Willis, L.H., Slentz, C.A., Houmard, J.A., Johnson, J.L., Duscha, B.D., Aiken, L.B., et al. Minimal versus umbilical waist circumference measures as indicators of cardiovascular disease risk. Obesity (Silver Spring Md) 15:3 (2007), 753–759.
22. Marshall, J.C., Dunaif, A., Should all women with PCOS be treated for insulin resistance?. Fertil Steril 97:1 (2012), 18–22.
23. Eslamparast, T., Zamani, F., Hekmatdoost, A., Sharafkhah, M., Eghtesad, S., Malekzadeh, R., et al. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr 112:3 (2014), 438–445.
24. Asemi, Z., Khorrami-Rad, A., Alizadeh, S.-A., Shakeri, H., Esmaillzadeh, A., Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 33:2 (2014), 198–203.
25. Kasinska, M.A., Drzewoski, J., Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Pol Arch Med Wewn 125:11 (2015), 803–813.
26. Ma, X., Hua, J., Li, Z., Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49:5 (2008), 821–830.
27. Mohamadshahi, M., Veissi, M., Haidari, F., Shahbazian, H., Kaydani, G.-A., Mohammadi, F., Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. BioImpacts BI, 4(2), 2014, 83.
28. Ahmadi, S., Jamilian, M., Karamali, M., Tajabadi-Ebrahimi, M., Jafari, P., Taghizadeh, M., et al. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil, 2017, 1–8.
29. Jung, S.-P., Lee, K.-M., Kang, J.-H., Yun, S.-I., Park, H.-O., Moon, Y., et al. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J Family Med 34:2 (2013), 80–89.
30. Carvalho, B.M., Abdalla Saad, M.J., Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediat Inflamm, 2013, 2013.
31. Marik, P.E., Colonic flora, probiotics, obesity and diabetes. Front Endocrinol, 3, 2012.
32. Zou, X., Yan, C., Shi, Y., Cao, K., Xu, J., Wang, X., et al. Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. Antioxidants Redox Signal 21:11 (2014), 1557–1570.
33. Szczuko, M., Skowronek, M., Zapalowska-Chwyc, M., Starczewski, A., Quantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS). Roczniki Panstwowego Zakladu Higieny 67:4 (2016), 419–426.
34. Holte, J., Bergh, T., Berne, C., Wide, L., Lithell, H., Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metabol 80:9 (1995), 2586–2593.
35. Glueck, C., Goldenberg, N., Wang, P., Loftspring, M., Sherman, A., Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 19:3 (2004), 510–521.